163 related articles for article (PubMed ID: 37097147)
1. Efficacy of Intravenously Administered Gepotidacin in Cynomolgus Macaques following a Francisella tularensis Inhalational Challenge.
Jakielaszek C; Hilliard JJ; Mannino F; Hossain M; Qian L; Fishman C; Chou YL; Henning L; Novak J; Demons S; Hershfield J; O'Dwyer K
Antimicrob Agents Chemother; 2023 May; 67(5):e0138122. PubMed ID: 37097147
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthrax.
Hilliard JJ; Jakielaszek C; Mannino F; Hossain M; Qian L; Fishman C; Demons S; Hershfield J; Soffler C; Russo R; Henning L; Novak J; O'Dwyer K
Antimicrob Agents Chemother; 2024 Mar; 68(3):e0149723. PubMed ID: 38358266
[No Abstract] [Full Text] [Related]
3. The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal Rule.
Guina T; Lanning LL; Omland KS; Williams MS; Wolfraim LA; Heyse SP; Houchens CR; Sanz P; Hewitt JA
Front Cell Infect Microbiol; 2018; 8():99. PubMed ID: 29670861
[No Abstract] [Full Text] [Related]
4. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques.
Grossman TH; Anderson MS; Christ D; Gooldy M; Henning LN; Heine HS; Kindt MV; Lin W; Siefkas-Patterson K; Radcliff AK; Tam VH; Sutcliffe JA
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559261
[TBL] [Abstract][Full Text] [Related]
5. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
[No Abstract] [Full Text] [Related]
6. The Natural History of Aerosolized
Frick OM; Livingston VA; Whitehouse CA; Norris SL; Alves DA; Facemire PR; Reed DS; Nalca A
Pathogens; 2021 May; 10(5):. PubMed ID: 34068262
[TBL] [Abstract][Full Text] [Related]
7. Comparison of experimental respiratory tularemia in three nonhuman primate species.
Glynn AR; Alves DA; Frick O; Erwin-Cohen R; Porter A; Norris S; Waag D; Nalca A
Comp Immunol Microbiol Infect Dis; 2015 Apr; 39():13-24. PubMed ID: 25766142
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of the Francisella tularensis ΔpdpC mutant against its virulent parental strain SCHU P9 in Cynomolgus macaques.
Tian D; Uda A; Ami Y; Hotta A; Park ES; Nagata N; Iwata-Yoshikawa N; Yamada A; Hirayama K; Miura K; Koyama Y; Azaki M; Morikawa S
Sci Rep; 2019 Jun; 9(1):9193. PubMed ID: 31235714
[TBL] [Abstract][Full Text] [Related]
9. Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.
Richard K; Mann BJ; Stocker L; Barry EM; Qin A; Cole LE; Hurley MT; Ernst RK; Michalek SM; Stein DC; Deshong P; Vogel SN
Clin Vaccine Immunol; 2014 Feb; 21(2):212-26. PubMed ID: 24351755
[TBL] [Abstract][Full Text] [Related]
10. Post-exposure immunization against Francisella tularensis membrane proteins augments protective efficacy of gentamicin in a mouse model of pneumonic tularemia.
Sutherland MD; Goodyear AW; Troyer RM; Chandler JC; Dow SW; Belisle JT
Vaccine; 2012 Jul; 30(33):4977-82. PubMed ID: 22652404
[TBL] [Abstract][Full Text] [Related]
11. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.
Golovliov I; Twine SM; Shen H; Sjostedt A; Conlan W
PLoS One; 2013; 8(11):e78671. PubMed ID: 24236032
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Doxycycline and Ciprofloxacin for Treatment of Pneumonic Tularemia in Cynomolgus Macaques.
Williams MS
Clin Infect Dis; 2024 Jan; 78(Suppl 1):S7-S14. PubMed ID: 38294111
[TBL] [Abstract][Full Text] [Related]
13. Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague.
Jakielaszek C; Hossain M; Qian L; Fishman C; Widdowson K; Hilliard JJ; Mannino F; Raychaudhuri A; Carniel E; Demons S; Heine HS; Hershfield J; Russo R; Mega WM; Revelli D; O'Dwyer K
Sci Transl Med; 2022 Jun; 14(647):eabg1787. PubMed ID: 35648812
[TBL] [Abstract][Full Text] [Related]
14. Development, Characterization, and Standardization of a Nose-Only Inhalation Exposure System for Exposure of Rabbits to Small-Particle Aerosols Containing Francisella tularensis.
O'Malley KJ; Bowling JD; Barry EM; Hazlett KRO; Reed DS
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31085702
[TBL] [Abstract][Full Text] [Related]
15. Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates.
Chu P; Cunningham AL; Yu JJ; Nguyen JQ; Barker JR; Lyons CR; Wilder J; Valderas M; Sherwood RL; Arulanandam BP; Klose KE
PLoS Pathog; 2014 Oct; 10(10):e1004439. PubMed ID: 25340543
[TBL] [Abstract][Full Text] [Related]
16. Global Analysis of Genes Essential for Francisella tularensis Schu S4 Growth
Ireland PM; Bullifent HL; Senior NJ; Southern SJ; Yang ZR; Ireland RE; Nelson M; Atkins HS; Titball RW; Scott AE
J Bacteriol; 2019 Apr; 201(7):. PubMed ID: 30642993
[TBL] [Abstract][Full Text] [Related]
17. Contributions of TolC Orthologs to
Kopping EJ; Doyle CR; Sampath V; Thanassi DG
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670554
[No Abstract] [Full Text] [Related]
18. The Natural History of Pneumonic Tularemia in Female Fischer 344 Rats after Inhalational Exposure to Aerosolized Francisella tularensis Subspecies tularensis Strain SCHU S4.
Hutt JA; Lovchik JA; Dekonenko A; Hahn AC; Wu TH
Am J Pathol; 2017 Feb; 187(2):252-267. PubMed ID: 27939130
[TBL] [Abstract][Full Text] [Related]
19. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
Twine S; Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
Vaccine; 2012 May; 30(24):3634-45. PubMed ID: 22484348
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
